HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Huang, Y.-H. Articles by Wu, J.-C. Search for Related Content PubMed PubMed Citation Articles by Huang, Y.-H. Articles by Wu, J.-C. Agricola Articles by Huang, Y.-H. Articles by Wu, J.-C.

Identification of novel HLA-A*0201-restricted CD8⁺ T-cell epitopes on hepatitis delta virus

¹ Institute of Clinical Medicine, National Yang-Ming University, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, 201 Shih-Pai Road, Sec. 2, Taipei 112, Taiwan, Republic of China
² Division of Cancer Research, Institute of Biomedical Science, Academia Sinica, Taipei, Taiwan, Republic of China
³ Department of Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China
⁴ Institute of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan, Republic of China

Correspondence
Jaw-Ching Wu
jcwu{at}vghtpe.gov.tw

Hepatitis delta virus (HDV) superinfection causes a poor prognosis in hepatitis B virus-infected patients and effective therapy is lacking. Cytotoxic T-lymphocyte (CTL) responses play an important role in the pathogenesis of chronic viral hepatitis; however, the CD8⁺ T-cell epitopes of HDV have never been defined. Potential HLA-A*0201-restricted HDV peptides were selected from the SYFPEITHI database and screened by T2 cell-stabilization assay. HLA-A*0201 transgenic mice on a C57BL/6 background were injected intramuscularly with an HDV DNA vaccine. Splenocytes were stained directly ex vivo with HLA-A*0201–peptide tetramers after immunization. Epitope-specific CTL responses were confirmed by cytotoxic assays. HLA-A2, chronically infected HDV patients were also enrolled, to assess the existence of HDV-specific CD8⁺ T cells, based on findings in animals. Following HDV DNA vaccination, nearly 0·9 % of the total splenic CD8⁺ T cells were specific for peptides HDV 26–34 and HDV 43–51 in HLA-A*0201 transgenic mice, which was significantly higher than the number found in non-transgenic mice or in transgenic mice that had been immunized with control plasmid. HDV 26–34- and 43–51-specific CTL lines were able to produce CTL responses to each peptide. Interestingly, HDV 26–34- and HDV 43–51-specific CD8⁺ T cells were also detectable in two chronically infected HDV patients in the absence of active HDV replication. In conclusion, HDV 26–34 and 43–51 are novel HLA-A*0201-restricted CTL epitopes on genotype I HDV. HDV 26–34- and 43–51-specific CTLs have been detected in chronic hepatitis delta patients without active disease. Evoking CTL responses to HDV may be an alternative approach to controlling HDV viraemia in patients with chronic hepatitis delta.

This article has been cited by other articles:

				S.-Y. Wang, J.-C. Wu, T.-Y. Chiang, Y.-H. Huang, C.-W. Su, and I-J. Sheen Positive Selection of Hepatitis Delta Antigen in Chronic Hepatitis D Patients J. Virol., May 1, 2007; 81(9): 4438 - 4444. [Abstract] [Full Text] [PDF]

				A. Boesen, K. Sundar, and R. Coico Lassa Fever Virus Peptides Predicted by Computational Analysis Induce Epitope-Specific Cytotoxic-T-Lymphocyte Responses in HLA-A2.1 Transgenic Mice Clin. Vaccine Immunol., October 1, 2005; 12(10): 1223 - 1230. [Abstract] [Full Text] [PDF]